friend24 - Pesquisar

Warning: Undefined array key "_get" in /home/senmarri/public_html/friend24.in/content/themes/default/templates_compiled/0a06b177eefe8e3ad797728f33ee676e0e5e4636_0.file.__feeds_post.tpl.php on line 73

Warning: Attempt to read property "value" on null in /home/senmarri/public_html/friend24.in/content/themes/default/templates_compiled/0a06b177eefe8e3ad797728f33ee676e0e5e4636_0.file.__feeds_post.tpl.php on line 73

adicionou um novo artigo
Warning: Undefined array key "_get" in /home/senmarri/public_html/friend24.in/content/themes/default/templates_compiled/fdb333d41d2393d1800b95e2a345a3e2864e9277_0.file.__feeds_post.body.tpl.php on line 509

Warning: Attempt to read property "value" on null in /home/senmarri/public_html/friend24.in/content/themes/default/templates_compiled/fdb333d41d2393d1800b95e2a345a3e2864e9277_0.file.__feeds_post.body.tpl.php on line 509

Warning: Undefined array key "_get" in /home/senmarri/public_html/friend24.in/content/themes/default/templates_compiled/fdb333d41d2393d1800b95e2a345a3e2864e9277_0.file.__feeds_post.body.tpl.php on line 515

Warning: Attempt to read property "value" on null in /home/senmarri/public_html/friend24.in/content/themes/default/templates_compiled/fdb333d41d2393d1800b95e2a345a3e2864e9277_0.file.__feeds_post.body.tpl.php on line 515

2025-06-23 06:16:10 - Traduzir -

PARP Inhibitors Market Analysis, Key Players & Forecast Outlook (2024–2032) | UnivDatos

Key Highlights of the Report: The PARP inhibitor market has experienced significant growth in recent years, driven by increasing cancer incidence and advancements in targeted cancer therapies. The market is projected to expand at a robust CAGR over the forecast period, reflecting rising adoption and awareness of PARP inhibitors in oncology. PARP inhibitors are primarily used in the treatment of...

0 Comentários 0 Compartilhamentos

2025-09-09 11:39:59 - Traduzir -

PARP Inhibitors Market Report, Size, Share, Trends & Forecast 2032

The PARP Inhibitors Market was valued at USD 4723.5 Million and is expected to grow at a strong CAGR of around 12.9% during the forecast period 2024-2032 Poly (ADP-ribose) polymerase (PARP) inhibitors have emerged as a revolutionary class of drugs in the treatment of cancer, majorly ovarian, breast, and prostate cancers. The demand for PARP inhibitors has grown subsequently in past few years,...

0 Comentários 0 Compartilhamentos